Join to view full profile
6445 Main Street, Floor 24Houston, TX 77030
Phone+1 713-441-9948
Dr. Matei is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1997 - 1999- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1993 - 1996
Carol Davila University of Medicine and PharmacyClass of 1992
Certifications & Licensure
CA State Medical License 1996 - Present
IL State Medical License 2015 - 2029
TX State Medical License 2026 - 2028
IN State Medical License 2002 - 2017
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2021 Mar 16
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Surgical window of opportunity clinical trial of abemaciclib and letrozole for endometrioid adenocarcinoma of the endometrium.Emma L Barber, Jian-Jun Wei, Amanda L Strickland, John W Moroney, Dario R Roque
Gynecologic Oncology. 2026-08-01 - Oleic acid fuels cisplatin-resistant ovarian cancer through FABP4-driven lipid uptake.Ana Maria Isac, Andres Valdivia, Didi Zha, Yinu Wang, Vanessa Hernandez
Molecular Metabolism. 2026-06-01 - 1 citationsPhase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxor...Yvette Drew, Lucy Gilbert, Alejandro Martinez Bueno, Ana Oaknin, Victor Moreno
British Journal of Cancer. 2026-06-01
Press Mentions
25 Cancer Center Leadership Moves in 2026March 5th, 2026- Houston Methodist Awarded $4M Grant to Recruit Head of Neal Cancer CenterFebruary 26th, 2026
- Targeting Tumor Metabolism to Trigger Cancer Cell DeathJune 4th, 2025
Grant Support
- Northwestern University Lead Academic Participating SiteNORTHWESTERN UNIVERSITY AT CHICAGO2026–2032
- Lipid Unsaturation Drives Ovarian Cancer ProgressionMETHODIST HOSPITAL RESEARCH INSTITUTE2018–2031
- Understanding Metabolic Reprogramming in Platinum Resistant Ovarian CancerJESSE BROWN VA MEDICAL CENTER2022–2027
- Northwestern University Center for Chromatin NanoImaging in Cancer (NU-CCNIC)NORTHWESTERN UNIVERSITY2021–2026
- Northwestern University Lead Academic Participating SiteNORTHWESTERN UNIVERSITY AT CHICAGO2019–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
